back to conferences

EU Simoa® Success Seminar: Lisbon


October 3-4, 2023


Lisbon, Portugal

October 3rd – 4th, 2023 | Hyatt Regency Lisbon, R. da Junqueira 65, 1300-343 Lisbon, Portugal

Optimize your Simoa® experience!

Connect with accomplished users of our ultrasensitive Simoa® technology and learn about assay development, Simoa® best practices, and more.

Join us for technical presentations from Quanterix and Simoa® users, workshops, Simoa® users poster session, and networking opportunities. Agenda is listed below. 


Day 1: Tuesday, 3rd October | Moderator: Danilo La Terra, Senior Field Application Scientist, Quanterix 
13.45-14.00 Registration 
14.00-14.10 Opening remarks Milena Milutinovic PhD, Senior Manager Field Applications, Quanterix 
14.10-14.40 Scaling up Simoa®: Preparing for large kit projects Lindsey Marsh PhD, Senior Field Application Scientist, Quanterix 
14.40-15.10 High sensitivity phenotyping of extracellular vesicles Alessandro Gori PhD, National Research Council of Italy (SCITEC-CNR) 
15.10-15.40 A CROs guide to homebrewing success: Awkward antibodies & sensitive solutions Daniel Creed, Senior Scientist, Resolian, UK 
15.40-16.10 Coffee break 
16.10-16.40 Simoa data analysis Victor Liman, Manager Technical Applications, Quanterix 
16.40-17.10 Quanterix service overview and qualification tips & tricks Quanterix Service Team 
17.10-17.40 Poster session 
19h Dinner 
Day 2: Wednesday, 4th October | Moderator: Ilaria Mancini, Field Application Scientist, Quanterix 
9.00-9.30 LucentAD and Quanterix’s diagnostic strategy Zachary Fernandes, Director, Global Channel Strategy, Quanterix 
9.30-10.00 The new normal – Detecting Alzheimer’s disease pathology through blood tests Hanna Huber PhD, Neurochemistry department at the University of Gothenburg, Sweden 
10.00-10.30 NfL reflects neuron damage in in vitro models of acute brain injury Massimiliano De Paola PhD, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy 
10.30-11.15 Coffee break 
11.15-11.30 Simoa® in oncology: Now and in future Byron Shen PhD, Director, Oncology Business Development, Quanterix 
11.30-11.45 Translational Simoa® sensitivity blood-based biomarkers for neurological drug development and clinical trial support Mark Roskey PhD, Chief Science and Collaboration Officer, Quanterix 
11.45-12.30 Simoa® Best practices, Open Discussion:Group A) HD-X, B) SR-X, C) SP-X 
12.30-12.45 Closing remarks Milena Milutinovic PhD, Senior Manager Field Applications, Quanterix